Expert Insights on Achieving Normalization for Hemophilia A Patients
By
Supported by an independent educational grant from Sobi.
Summary
This article features Cedric Hermans, MD, PhD, FRCP, a professor and head of hematology at Saint-Luc University Hospital in Brussels, discussing the normalization of life for patients with Hemophilia A. The content focuses on whether normalization can be achieved for all patients and provides expert resources and insights to enhance hematology practice. The article includes disclosures of the author's financial relationships and affiliations with numerous pharmaceutical and biotechnology companies including CSL Behring, Sobi, Biogen, BioMarin, Roche, Sanofi, Takeda, and others.
Source
Twitter / XExpert Insights on Achieving Normalization for Hemophilia A Patientsmdsc.peKey quotes
· 2 pulledCan normalization be achieved for all patients with hemophilia A?
Access expert resources and current insights to enhance your hematology practice.
You might also wanna read
https://doi.org/10.1056/NEJMoa2517384
First New York patient cured of sickle cell disease using Lyfgenia gene therapy
Sebastien Beauzile, a 21-year-old living with sickle cell anemia, has become the first person in New York State to be cured of the disease u
Dra. Sacramento Pinazo: Les cooperatives de cures com a canvi estructural en l'atenció a la gent gran
La doctora Sacramento Pinazo-Hernandis, experta en gerontologia i envelliment, defensa en aquesta entrevista/anàlisi que les cooperatives de
ara.cat·1d ago
Deep phenotyping of skin tissue remodeling in patients with systemic sclerosis treated with CD19-CAR T cells
Comments
Sign in to join the conversation.
No comments yet. Be the first.